PPARA and metabolic dysfunction-associated steatotic liver disease: Other related reports showed that GpS protected against NAFLD progression by upregulating the expression of PPARα and downregulating the inflammatory cytokines, oxidative stress indices, and de novo lipogenesis (Gou et al., 2016; He et al., 2015; Qin et al., 2012).